Loading...
Antibiotics Approved for Marketing in Populations Specifically Excluded From Premarketing Trials, 1999–2018
Approval by the US Food and Drug Administration (FDA) of a drug for a given indication is thought to reassure clinicians, other health care providers, and patients that substantial evidence of effectiveness exists for specific indicated populations (patients and diseases). This study examines whethe...
Saved in:
| Published in: | Mayo Clin Proc |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8080959/ https://ncbi.nlm.nih.gov/pubmed/33276841 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mayocp.2020.07.023 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|